InnerVision's platform technology is being developed initially for the diagnosis of breast cancer, prostate cancer and pharmaceutical research and development. The platform has broad market potential in diagnosis of disease.

The technology has the potential to be used alone, or in tandem with MRI, CT, PET and other types of scans.

Imaging modalities that detect disease prior to the development of symptoms, and help prove the efficacy of drugs under development, offer tremendous potential for extending human life.

Note:
Flash Ultrasound™ is an Investigational Device. It is not currently available for sale. Confirmation of safety and effectiveness is yet to be determined.